FI921794A - Foerfarande foer framstaellning av n-imidazolylderivat av substituerad indol - Google Patents
Foerfarande foer framstaellning av n-imidazolylderivat av substituerad indol Download PDFInfo
- Publication number
- FI921794A FI921794A FI921794A FI921794A FI921794A FI 921794 A FI921794 A FI 921794A FI 921794 A FI921794 A FI 921794A FI 921794 A FI921794 A FI 921794A FI 921794 A FI921794 A FI 921794A
- Authority
- FI
- Finland
- Prior art keywords
- framework
- indol
- substitutes
- imidazole derivatives
- imidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919108811A GB9108811D0 (en) | 1991-04-24 | 1991-04-24 | N-imidazolyl derivatives of substituted indole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI921794A0 FI921794A0 (fi) | 1992-04-22 |
| FI921794A true FI921794A (fi) | 1992-10-25 |
Family
ID=10693860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI921794A FI921794A (fi) | 1991-04-24 | 1992-04-22 | Foerfarande foer framstaellning av n-imidazolylderivat av substituerad indol |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5246957A (ru) |
| EP (1) | EP0510398A3 (ru) |
| JP (1) | JPH05132482A (ru) |
| KR (1) | KR920019779A (ru) |
| AU (1) | AU647907B2 (ru) |
| CA (1) | CA2066938A1 (ru) |
| FI (1) | FI921794A (ru) |
| GB (1) | GB9108811D0 (ru) |
| HU (1) | HUT60730A (ru) |
| IE (1) | IE921314A1 (ru) |
| IL (1) | IL101453A (ru) |
| MX (1) | MX9201805A (ru) |
| MY (1) | MY131096A (ru) |
| NZ (1) | NZ242377A (ru) |
| RU (1) | RU2073669C1 (ru) |
| TW (1) | TW213911B (ru) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5451597A (en) * | 1993-05-27 | 1995-09-19 | G.D. Searle & Co. | Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists |
| AU685122B2 (en) * | 1993-06-14 | 1998-01-15 | Pfizer Inc. | Imidazole lipoxygenase inhibitors |
| JPH0867866A (ja) | 1994-06-20 | 1996-03-12 | Canon Inc | 光重合剤及び／又は光架橋剤に対する可視光増感剤、感光性組成物及びホログラム記録媒体 |
| TW397821B (en) * | 1996-04-19 | 2000-07-11 | American Home Produits Corp | 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof |
| US5880137A (en) * | 1996-04-19 | 1999-03-09 | American Home Products Corporation | 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents |
| DE69830069T3 (de) * | 1997-10-17 | 2012-02-09 | Ark Therapeutics Ltd. | Verwendung von hemmern des renin-angiotensin systems zur behandlung von hypoxie oder verringertem stoffwechsel |
| US6069153A (en) * | 1998-05-12 | 2000-05-30 | American Home Products Corporation | Indenoindoles and benzocarbazoles as estrogenic agents |
| US6479535B1 (en) | 1998-05-15 | 2002-11-12 | Wyeth | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
| US6159959A (en) * | 1999-05-06 | 2000-12-12 | American Home Products Corporation | Combined estrogen and antiestrogen therapy |
| CA2565628A1 (en) * | 2004-05-03 | 2005-11-10 | Astellas Pharma Inc. | The combination of prostaglandin e2 receptor antagonist and renin-angiotensin system inhibitor for treating renal diseases |
| US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| TW200920369A (en) | 2007-10-26 | 2009-05-16 | Amira Pharmaceuticals Inc | 5-lipoxygenase activating protein (flap) inhibitor |
| MX2010012814A (es) | 2008-05-23 | 2010-12-20 | Amira Pharmaceuticals Inc | Inhibidor de proteina activadora de 5-lipoxigenasa. |
| US8546431B2 (en) | 2008-10-01 | 2013-10-01 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH455777A (de) * | 1965-05-13 | 1968-05-15 | Geigy Ag J R | Verfahren zur Herstellung von neuen Indolderivaten |
| GR75101B (ru) * | 1980-10-23 | 1984-07-13 | Pfizer | |
| ZA825413B (en) * | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
| CA1241660A (en) * | 1984-06-25 | 1988-09-06 | Yvan Guindon | Indole-2-alkanoic acids |
| JPS63501215A (ja) * | 1985-10-30 | 1988-05-12 | ジ・アップジョン・カンパニー | ３’−ピリジニルアルキルインデン−および３’−ピリジニルアルキルインドール−２−カルボン酸および同族体 |
| NZ222878A (en) * | 1986-12-17 | 1991-02-26 | Merck Frosst Canada Inc | 3-hetero-substituted-n-benzyl-indole derivatives, and pharmaceutical compositions |
| US5081138A (en) * | 1986-12-17 | 1992-01-14 | Merck Frosst Canada, Inc. | 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith |
| GB8814277D0 (en) * | 1988-06-16 | 1988-07-20 | Glaxo Group Ltd | Chemical compounds |
| IL91542A0 (en) * | 1988-10-06 | 1990-04-29 | Erba Carlo Spa | N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them |
| IT1227362B (it) * | 1988-11-18 | 1991-04-08 | Istituto Biochimico Italiano | Derivati indolici, processo per la loro preparazione e loro uso comefarmaci antitrombotici |
| DE4010797A1 (de) * | 1990-04-04 | 1991-10-10 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
-
1991
- 1991-04-24 GB GB919108811A patent/GB9108811D0/en active Pending
-
1992
- 1992-04-02 IL IL10145392A patent/IL101453A/en not_active IP Right Cessation
- 1992-04-02 EP EP19920105650 patent/EP0510398A3/en not_active Ceased
- 1992-04-07 AU AU14079/92A patent/AU647907B2/en not_active Ceased
- 1992-04-10 HU HU9201246A patent/HUT60730A/hu unknown
- 1992-04-10 MY MYPI92000610A patent/MY131096A/en unknown
- 1992-04-15 NZ NZ242377A patent/NZ242377A/xx unknown
- 1992-04-16 TW TW081102997A patent/TW213911B/zh active
- 1992-04-17 US US07/870,084 patent/US5246957A/en not_active Expired - Fee Related
- 1992-04-20 MX MX9201805A patent/MX9201805A/es unknown
- 1992-04-22 FI FI921794A patent/FI921794A/fi not_active Application Discontinuation
- 1992-04-23 IE IE131492A patent/IE921314A1/en unknown
- 1992-04-23 KR KR1019920006840A patent/KR920019779A/ko not_active Application Discontinuation
- 1992-04-23 CA CA002066938A patent/CA2066938A1/en not_active Abandoned
- 1992-04-23 JP JP4104910A patent/JPH05132482A/ja active Pending
- 1992-04-23 RU SU925011371A patent/RU2073669C1/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| HU9201246D0 (en) | 1992-07-28 |
| EP0510398A3 (en) | 1993-01-13 |
| IE921314A1 (en) | 1992-11-04 |
| RU2073669C1 (ru) | 1997-02-20 |
| KR920019779A (ko) | 1992-11-20 |
| FI921794A0 (fi) | 1992-04-22 |
| EP0510398A2 (en) | 1992-10-28 |
| AU1407992A (en) | 1992-10-29 |
| CA2066938A1 (en) | 1992-10-25 |
| US5246957A (en) | 1993-09-21 |
| AU647907B2 (en) | 1994-03-31 |
| GB9108811D0 (en) | 1991-06-12 |
| JPH05132482A (ja) | 1993-05-28 |
| TW213911B (ru) | 1993-10-01 |
| IL101453A0 (en) | 1992-12-30 |
| NZ242377A (en) | 1993-09-27 |
| HUT60730A (en) | 1992-10-28 |
| IL101453A (en) | 1996-05-14 |
| MX9201805A (es) | 1994-07-29 |
| MY131096A (en) | 2007-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK43193D0 (da) | Indolderivater | |
| FI921794A (fi) | Foerfarande foer framstaellning av n-imidazolylderivat av substituerad indol | |
| NO912051D0 (no) | Fremgangsmaate for fremstilling av azolderivater. | |
| FI921437A (fi) | Foerfarande foer framstaellning av jaemnstora jonbyteshartspartiklar | |
| DE69212058D1 (de) | Indol-Derivate | |
| NO940237D0 (no) | Indoler | |
| NO924028L (no) | Forbedret fremgangsmaate for fremstilling av substituerte indolonderivater | |
| FI931033A0 (fi) | Foerfarande foer framstaellning av dialkyl-2,3-pyridindikarboxylat och derivat daerav ur a,b-omaettade oximer och aminobutendioat | |
| NO914056D0 (no) | Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat | |
| NO992058D0 (no) | FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eseretoler | |
| NO914053L (no) | Fremgangsmaate for fremstilling av 8-klorokinolonderivater | |
| NO952713D0 (no) | Fremgangsmåte for fremstilling av substituerte indolonderivater | |
| FI931189A (fi) | Foerfaranden foer framstaellning av 17b-substituerade 4-aza-5a-androstan-3-onderivat | |
| NO924532D0 (no) | Fremgangsmaate for fremstilling av triazinderivater | |
| NO914985D0 (no) | Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater | |
| NO932616D0 (no) | Fremgangsmaate for fremstilling av fysostigminkarbonatderivater fra fysostigmin | |
| NO179866C (no) | Fremgangsmåte for fremstilling av indoler | |
| FI951047A (fi) | Menetelmä indolijohdannaisten valmistamiseksi | |
| NO925007D0 (no) | Fremgangsmaate for fremstilling av benzofuranylimidazolderivater | |
| NO911672L (no) | Fremgangsmaate for fremstilling av alkansulfonanilid-derivater. | |
| NO914452L (no) | Fremgangsmaate for fremstilling av isokinolinderivater | |
| FI830939A0 (fi) | Foerfarande foer framstaellning av nya derivat av indolizino(8,7-b)indol | |
| FI960929A0 (fi) | Välituotteena käyttökelpoiset indolonijohdannaiset | |
| FI932901A (fi) | Foerfarande foer framstaellning av alkalimonofluorfosfat | |
| DE69127345D1 (de) | Mitomycinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |